Search research articles
Contact Us
Filters
Showing results (81-90 of 95) with videos related to
Page
of 10
Sort By:
Scientific Reports
|
May 23, 2015
Swirl Flow Bioreactor coupled with Cu-alginate beads: A system for the eradication of Coliform and Escherichia coli from biological effluents
Sov Atkinson, Simon F Thomas, Paul Goddard, et al.
CNS & Neurological Disorders Drug Targets
|
April 12, 2013
mGlu2/3 agonist-induced hyperthermia: an in vivo assay for detection of mGlu2/3 receptor antagonism and its relation to antidepressant-like efficacy in mice
S D Gleason, X Li, I A Smith, et al.
CNS & Neurological Disorders Drug Targets
|
April 30, 2015
Inquiries into the Biological Significance of Transmembrane AMPA Receptor Regulatory Protein (TARP) γ-8 Through Investigations of TARP γ-8 Null Mice§
Scott D Gleason, Akihiko Kato, Hai H Bui, et al.
Pharmacology, Biochemistry, and Behavior
|
April 27, 2017
Further evaluation of the potential anxiolytic activity of imidazo[1,5-a][1,4]diazepin agents selective for α2/3-containing GABA<sub>A</sub> receptors
J M Witkin, R Cerne, M Wakulchik, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
July 17, 2014
Perampanel, an antagonist of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors, for the treatment of epilepsy: studies in human epileptic brain and nonepileptic brain and in rodent models
R Zwart, E Sher, X Ping, et al.
CNS & Neurological Disorders Drug Targets
|
November 2, 2017
Targeted Blockade of TARP-γ8-Associated AMPA Receptors: Anticonvulsant Activity with the Selective Antagonist LY3130481 (CERC-611)
Jeffrey M Witkin, Douglas A Schober, Scott D Gleason, et al.
Neuropharmacology
|
August 1, 2017
Electroencephalographic, cognitive, and neurochemical effects of LY3130481 (CERC-611), a selective antagonist of TARP-γ8-associated AMPA receptors
Jeffrey M Witkin, Jennifer Li, Gary Gilmour, et al.
Psychopharmacology
|
January 28, 2018
Negative allosteric modulation of alpha 5-containing GABA<sub>A</sub> receptors engenders antidepressant-like effects and selectively prevents age-associated hyperactivity in tau-depositing mice
Nina Z Xu, Margot Ernst, Marco Treven, et al.
Pharmacology, Biochemistry, and Behavior
|
May 2, 2018
An antidepressant-related pharmacological signature for positive allosteric modulators of α2/3-containing GABA<sub>A</sub> receptors
K R Methuku, X Li, R Cerne, et al.
Biochemical Pharmacology
|
June 26, 2018
Pharmacological characterization of the neurotrophic sesquiterpene jiadifenolide reveals a non-convulsant signature and potential for progression in neurodegenerative disease studies
Jeffrey M Witkin, Ryan A Shenvi, Xia Li, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 95) with videos related to
Sort By:
Page
of 10
Scientific Reports
|
May 23, 2015
Swirl Flow Bioreactor coupled with Cu-alginate beads: A system for the eradication of Coliform and Escherichia coli from biological effluents
Sov Atkinson, Simon F Thomas, Paul Goddard, et al.
CNS & Neurological Disorders Drug Targets
|
April 12, 2013
mGlu2/3 agonist-induced hyperthermia: an in vivo assay for detection of mGlu2/3 receptor antagonism and its relation to antidepressant-like efficacy in mice
S D Gleason, X Li, I A Smith, et al.
CNS & Neurological Disorders Drug Targets
|
April 30, 2015
Inquiries into the Biological Significance of Transmembrane AMPA Receptor Regulatory Protein (TARP) γ-8 Through Investigations of TARP γ-8 Null Mice§
Scott D Gleason, Akihiko Kato, Hai H Bui, et al.
Pharmacology, Biochemistry, and Behavior
|
April 27, 2017
Further evaluation of the potential anxiolytic activity of imidazo[1,5-a][1,4]diazepin agents selective for α2/3-containing GABA<sub>A</sub> receptors
J M Witkin, R Cerne, M Wakulchik, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
July 17, 2014
Perampanel, an antagonist of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors, for the treatment of epilepsy: studies in human epileptic brain and nonepileptic brain and in rodent models
R Zwart, E Sher, X Ping, et al.
CNS & Neurological Disorders Drug Targets
|
November 2, 2017
Targeted Blockade of TARP-γ8-Associated AMPA Receptors: Anticonvulsant Activity with the Selective Antagonist LY3130481 (CERC-611)
Jeffrey M Witkin, Douglas A Schober, Scott D Gleason, et al.
Neuropharmacology
|
August 1, 2017
Electroencephalographic, cognitive, and neurochemical effects of LY3130481 (CERC-611), a selective antagonist of TARP-γ8-associated AMPA receptors
Jeffrey M Witkin, Jennifer Li, Gary Gilmour, et al.
Psychopharmacology
|
January 28, 2018
Negative allosteric modulation of alpha 5-containing GABA<sub>A</sub> receptors engenders antidepressant-like effects and selectively prevents age-associated hyperactivity in tau-depositing mice
Nina Z Xu, Margot Ernst, Marco Treven, et al.
Pharmacology, Biochemistry, and Behavior
|
May 2, 2018
An antidepressant-related pharmacological signature for positive allosteric modulators of α2/3-containing GABA<sub>A</sub> receptors
K R Methuku, X Li, R Cerne, et al.
Biochemical Pharmacology
|
June 26, 2018
Pharmacological characterization of the neurotrophic sesquiterpene jiadifenolide reveals a non-convulsant signature and potential for progression in neurodegenerative disease studies
Jeffrey M Witkin, Ryan A Shenvi, Xia Li, et al.
Page
of 10